)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Assertio (ASRT) investor relations material
Assertio Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary10 Nov, 2025
Executive summary
Q3 2025 net product sales rose to $49.5M from $28.7M year-over-year, driven by Rolvedon sales pull forward, distributor stocking, and integration efforts.
CEO transition in October 2025, with Mark L. Reisenauer appointed and Paul Schwichtenberg promoted to President and COO, ensuring leadership continuity and strategic execution.
Ceased Otrexup commercialization in July 2025, incurring one-time costs and impacting other product sales.
Divested Assertio Therapeutics in May 2025, resulting in an $8.2M loss and removal of opioid litigation exposure.
Advanced integration of subsidiaries and product lines under a single commercial entity for efficiency and cost savings.
Financial highlights
Q3 2025 net product sales were $49.5M, up from $28.7M; Rolvedon sales surged to $38.6M from $15.0M year-over-year.
Adjusted EBITDA for Q3 2025 was $20.9M, up from $4.4M; nine-month adjusted EBITDA was $26.8M, up from $14.9M.
Q3 2025 net income was $11.4M (GAAP), compared to a net loss of $2.9M in Q3 2024.
Gross margin was 72%, down from 74%, impacted by higher Rolvedon sales mix and Otrexup costs.
Cash, cash equivalents, and short-term investments totaled $93.4M as of September 30, 2025, down from $98.2M at June 30, 2025.
Outlook and guidance
FY2025 net product sales guidance narrowed to $110M–$112M and adjusted EBITDA to $14M–$16M, reflecting Rolvedon demand pull-forward and portfolio impacts.
No material Rolvedon sales expected in Q4 2025 and Q1 2026; regular sales to resume in Q2 2026.
Cash balances expected to decline in Q4 2025 and Q1 2026, then recover in Q2 2026 as receivables are collected.
Guidance reflects negative impacts from Indocin generic competition and Otrexup decommercialization.
Ongoing legal expenses and settlements expected to remain a significant cash use for the remainder of 2025.
What is the cash flow impact of Rolvedon pull-forward?
New CEO's strategic priorities update?
What drives Sympazan sales acceleration?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Assertio earnings date
Q4 202510 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Assertio Holdings Inc. is a pharmaceutical company focused on the development, marketing, and distribution of prescription medications. The company specializes in providing treatments for patients with chronic pain, neurological disorders, and other medical conditions. Assertio's portfolio includes a range of therapies aimed at improving patient quality of life, with an emphasis on non-opioid options for pain management. The company is headquartered in Lake Forest, Illinois, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage